Multiple Sclerosis Clinical Trials

Showing 821-840 of 5,960 trials

Observational Study of the Effect of Ozanimod on Fatigue in Multiple Sclerosis Patients

NCT05319093

Multi-center observational study to assess the short-term response of multiple sclerosis (MS) patients initiated on Ozanimod with respect to fatigue. Patterns of brain changes on brain magnetic resonance imaging (MRI) that might modulate the effect of Ozanimod treatment on fatigue will also be assessed.

FatigueMultiple Sclerosis

Brigham and Women's Hospital26 participantsStarted Apr 2022

Boston, Massachusetts, United States

Enrolling By InvitationEARLY Phase 1

Clinical Evaluation of [68Ga]Ga-NOTA-RF PET Imaging Targeting RFVT3 in Patients With Pituitary Tumors

NCT07254104

This study aims to evaluate the clinical application value of \[68Ga\]Ga-NOTA-RF, a novel PET molecular probe targeting riboflavin transporter 3 (RFVT3), in patients with pituitary adenomas. It will observe the probe's imaging characteristics, distribution signs, and the relationships between these factors, tumor differentiation degree, and radiotracer uptake. Additionally, the study will explore the diagnostic advantages of \[68Ga\]Ga-NOTA-RF in patients with pituitary adenomas and its potential value in precise typing.

Pituitary Neoplasms

Peking Union Medical College Hospital30 participantsStarted Nov 2025

Beijing, China

Active Not RecruitingPhase 1

RT-310 Dose Escalation BPH Study

NCT06136819

RT-310, a novel implant, is intended to minimally invasive treat locally the prostate gland for the management of prostate disease, while minimizing side-effects. The objectives of the study are to assess whether RT-310 is safe and feasible for the participant population.

BPH (Benign Prostatic Hyperplasia)Lower Urinary Tract Symptoms

Resurge Therapeutics Inc.20 participantsStarted Apr 2024

Wahroonga, New South Wales, Australia • Bendigo, Victoria, Australia • Maribyrnong, Victoria, Australia +1 more locations

Observational Study of the Effect of Ozanimod on Fatigue in Multiple Sclerosis Patients

Clinical Evaluation of [68Ga]Ga-NOTA-RF PET Imaging Targeting RFVT3 in Patients With Pituitary Tumors

RT-310 Dose Escalation BPH Study

Related Searches

This Study Aims to Find the Best Dose of BI 907828 (Brigimadlin) in Patients With Different Types of Advanced Cancer (Solid Tumors)

Portal Vein Stenting for Malignant Obstruction: Feasibility, Safety, and Clinical Outcomes

A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT

Pilot Sleep Extension and Mood

Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042

Study of Ovarian Reserve Concerning Patients With Multiple Sclerosis (MS), Compared to a Control Group

Ocrelizumab Access by Socio-Economic Status

DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition

Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC)

PREG-MS: New England MS Pregnancy Registry

The Effect of Abdominal Massage Applied to Patients by Caregivers in Palliative Care Clinics on Gastrointestinal Symptoms

POWER Study (Prospective Transbronchial Microwave + Robotic-Assisted Bronchoscopy)

HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)

Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer

Impact on Quality of Life 3 Years After Diagnosis of Prostate Cancer

Effect of Using Bitter Melon, Blueberries and Cranberries on HbA1c and Diabetes Symptom Levels

MB-CART2019.1 in Refractory Multiple Sclerosis